{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:17:32Z","timestamp":1783163852428,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFC3508205"],"award-info":[{"award-number":["2025YFC3508205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271159"],"award-info":[{"award-number":["82271159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425018"],"award-info":[{"award-number":["82425018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271170"],"award-info":[{"award-number":["82271170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82192861"],"award-info":[{"award-number":["82192861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.heares.2026.109657","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:26:10Z","timestamp":1778423170000},"page":"109657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A Tumor-Bearing Mouse Model of Cisplatin-Induced Hearing Loss for Preclinical Otoprotectant Evaluation"],"prefix":"10.1016","volume":"477","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-7526","authenticated-orcid":false,"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2026.109657_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125948","article-title":"Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity","volume":"14","author":"Al Aameri","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.heares.2026.109657_bib0038","first-page":"302","article-title":"Neutrophils as effector cells of T-cell-mediated, acquired immunity in murine listeriosis","volume":"83","author":"Appelberg","year":"1994","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.heares.2026.109657_bib0030","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.7150\/thno.49121","article-title":"Neutrophils infiltrate into the spiral ligament but not the stria vascularis in the cochlea during lipopolysaccharide-induced inflammation","volume":"11","author":"Bae","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.heares.2026.109657_bib0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15252\/emmm.201606230","article-title":"Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy","volume":"9","author":"Benkafadar","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.heares.2026.109657_bib0002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-024-02028-5","article-title":"Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer","volume":"23","author":"Bharti","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.heares.2026.109657_bib0044","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0b013e32835739fd","article-title":"An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect","author":"Bielefeld","year":"2013","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.heares.2026.109657_bib0043","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1038\/cddis.2017.314","article-title":"Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity","volume":"8","author":"Borse","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.heares.2026.109657_bib0023","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat Commun"},{"issue":"25","key":"10.1016\/j.heares.2026.109657_bib0011","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss","volume":"378","author":"Brock","year":"2018","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.heares.2026.109657_bib0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra2020394","article-title":"Vestibular Schwannomas","volume":"384","author":"Carlson","year":"2021","journal-title":"N Engl J Med"},{"issue":"10192","key":"10.1016\/j.heares.2026.109657_bib0041","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.heares.2026.109657_bib0017","article-title":"Pinoresinol Diglucoside Attenuates Nuclear Receptor Coactivator 4-Mediated Ferritinophagy Associated with Cisplatin-Induced Hearing Loss","author":"Chen","year":"2025","journal-title":"Adv Sci."},{"key":"10.1016\/j.heares.2026.109657_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070499","article-title":"Advances in diagnosis and treatment of testicular cancer","volume":"379","author":"Chovanec","year":"2022","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.heares.2026.109657_bib0033","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/annonc\/mdx360","article-title":"Long-term toxicity of cisplatin in germ-cell tumor survivors","volume":"28","author":"Chovanec","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.heares.2026.109657_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2019.107878","article-title":"Cisplatin-induced threshold shift in the CBA\/CaJ, C57BL\/6J, BALB\/cJ mouse models of hearing loss","volume":"387","author":"DeBacker","year":"2020","journal-title":"Hear Res"},{"issue":"5","key":"10.1016\/j.heares.2026.109657_bib0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.heares.2026.109657_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2014.04.123","article-title":"Rapamycin alleviates cisplatin-induced ototoxicity in vivo","author":"Fang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.heares.2026.109657_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142616","article-title":"Atorvastatin is associated with reduced cisplatin-induced hearing loss","volume":"131","author":"Fernandez","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.heares.2026.109657_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.heares.2026.109657_bib0028","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2352-4642(19)30336-0","article-title":"Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline","volume":"4","author":"Freyer","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.heares.2026.109657_bib0036","article-title":"Oral AZD5438 is a clinically translatable otoprotectant against cisplatin-induced hearing loss","volume":"71","author":"Huang","year":"2025","journal-title":"Neoplasia N Y N"},{"issue":"3","key":"10.1016\/j.heares.2026.109657_bib0013","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00263891","article-title":"Inactivation of cis-diamminedichloroplatinum (II) in blood and protection of its toxicity by sodium thiosulfate in rabbits","volume":"15","author":"Iwamoto","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.heares.2026.109657_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2022.108518","article-title":"Inner ear immunity","volume":"419","author":"Keithley","year":"2022","journal-title":"Hear Res"},{"issue":"8","key":"10.1016\/j.heares.2026.109657_bib0009","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.32698","article-title":"The experience of hearing loss in adult survivors of childhood and young adult cancer: A qualitative study","volume":"126","author":"Khan","year":"2020","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.heares.2026.109657_bib0006","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative Chemoradiotherapy for Resectable Gastric Cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.heares.2026.109657_bib0021","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.freeradbiomed.2023.11.025","article-title":"Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss","volume":"210","author":"Liao","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.heares.2026.109657_bib0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tins.2022.12.002","article-title":"The evolutionary tuning of hearing","volume":"46","author":"Lipovsek","year":"2023","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.heares.2026.109657_bib0042","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ymthe.2024.02.029","article-title":"Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL\/6 mice","volume":"32","author":"Liu","year":"2024","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.heares.2026.109657_bib0048","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jare.2023.11.020","article-title":"CORM\u20112 reduces cisplatin accumulation in the mouse inner ear and protects against cisplatin-induced ototoxicity","volume":"64","author":"Lyu","year":"2023","journal-title":"J Adv Res"},{"key":"10.1016\/j.heares.2026.109657_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/icb.2008.6","article-title":"Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity","author":"Lonyai","year":"2008","journal-title":"Immunol Cell Biol. Published online"},{"issue":"6","key":"10.1016\/j.heares.2026.109657_bib0001","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.heares.2026.109657_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.apsb.2021.07.002","article-title":"Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo","volume":"12","author":"Nan","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"1-2","key":"10.1016\/j.heares.2026.109657_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.heares.2011.04.003","article-title":"The spiral ganglion: connecting the peripheral and central auditory systems","volume":"278","author":"Nayagam","year":"2011","journal-title":"Hear Res"},{"key":"10.1016\/j.heares.2026.109657_bib0018","unstructured":"NIH Guidelines for Endpoints in Animal Study Proposals. Accessed December 24, 2025. https:\/\/norecopa.no\/3r-guide\/nih-guidelines-for-endpoints-in-animal-study-proposals."},{"issue":"4","key":"10.1016\/j.heares.2026.109657_bib0027","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1152\/physrev.00030.2017","article-title":"Voltage-Gated Calcium Channels: Key Players in Sensory Coding in the Retina and the Inner Ear","volume":"98","author":"Pangrsic","year":"2018","journal-title":"Physiol Rev"},{"issue":"18","key":"10.1016\/j.heares.2026.109657_bib0004","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.21.02051","article-title":"Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial","volume":"40","author":"Pfister","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.heares.2026.109657_bib0032","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamaoncol.2024.1233","article-title":"Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy","volume":"10","author":"Sanchez","year":"2024","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.heares.2026.109657_bib0012","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1039\/c2mt20076g","article-title":"The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro","volume":"4","author":"Sooriyaarachchi","year":"2012","journal-title":"Metallomics"},{"issue":"11","key":"10.1016\/j.heares.2026.109657_bib0014","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1039\/C6MT00183A","article-title":"Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy","volume":"8","author":"Sooriyaarachchi","year":"2016","journal-title":"Met Integr Biometal Sci"},{"issue":"9","key":"10.1016\/j.heares.2026.109657_bib0020","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41596-022-00709-3","article-title":"The cell-line-derived subcutaneous tumor model in preclinical cancer research","volume":"17","author":"Stribbling","year":"2022","journal-title":"Nat Protoc"},{"issue":"22","key":"10.1016\/j.heares.2026.109657_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216545","article-title":"Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions","volume":"24","author":"Tan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.heares.2026.109657_bib0022","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.20172246","article-title":"CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss","volume":"215","author":"Teitz","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.heares.2026.109657_bib0007","article-title":"Cisplatin-induced ototoxicity: From signaling network to therapeutic targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"1-2","key":"10.1016\/j.heares.2026.109657_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0378-5955(97)00189-5","article-title":"The BALB\/c mouse as an animal model for progressive sensorineural hearing loss","volume":"115","author":"Willott","year":"1998","journal-title":"Hear Res"},{"key":"10.1016\/j.heares.2026.109657_bib0008","unstructured":"World Report on Hearing. 1st ed. World Health Organization; 2021."},{"key":"10.1016\/j.heares.2026.109657_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroscience.2025.08.053","article-title":"A multi-channel integrated auditory function test system","volume":"585","author":"Xiao","year":"2025","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.heares.2026.109657_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10162-024-00945-2","article-title":"FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect","volume":"25","author":"Yao","year":"2024","journal-title":"J Assoc Res Otolaryngol JARO"},{"issue":"1","key":"10.1016\/j.heares.2026.109657_bib0031","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-024-01974-2","article-title":"Surufatinib plus toripalimab combined with etoposide and cisplatin as first-line treatment in advanced small-cell lung cancer patients: a phase Ib\/II trial","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595526001334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595526001334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:47Z","timestamp":1783161587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595526001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"alternative-id":["S0378595526001334"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2026.109657","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Tumor-Bearing Mouse Model of Cisplatin-Induced Hearing Loss for Preclinical Otoprotectant Evaluation","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2026.109657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109657"}}